Home › NCT06100263
Breast Cancer Resiliency Through Exercise Program (B-REP)
Recruiting
Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: Women will be eligible if they meet the following criteria: * self-identify as Black or African American or Afro-Latina/e; * are ≥18 years old; * have a confirmed diagnosis of breast cancer, Stage I to IIIA; * have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable; * are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and * are able to speak and understand English. Exclusion Criteria: * metastatic disease; * medical reason that precludes them from increasing current exercise levels; * planned elective surgery during study period; * pregnant or plans to become pregnant during the study period; * plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States); * current enrollment in another exercise trial; and/or * inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.
About the study
The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors
What is being tested
- Individualized exercise program (other)
- Control Arm (other)
Sponsor: University of Michigan Rogel Cancer Center · Participants: 75 · Started: May 28, 2024
Contact the study team
- Cancer AnswerLine · Phone: 1-800-865-1125
Official record on ClinicalTrials.gov — NCT06100263
Locations in the U.S.
| Michigan | University of Michigan, Ann Arbor |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.